Carl Zeiss Meditec AG (MIL:1AFX) Payments of Debt: €4 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIL:1AFX Carl Zeiss Meditec AG MIL:1AFX
51 GF Score
Price €29.20
GF Value €63.89
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Carl Zeiss Meditec AG Payments of Debt?

Carl Zeiss Meditec AG MIL:1AFX 51 Payments of Debt is €4 Mil as of Mar. 2026. GuruFocus rates MIL:1AFX with a GF Score™ of 51/100 and a GF Value™ of €63.89 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Carl Zeiss Meditec AG's Payments of Debt for the six months ended in Mar. 2026 was €4 Mil.

Carl Zeiss Meditec AG's Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2026 was €4 Mil.

Carl Zeiss Meditec AG Payments of Debt Related Terms

Carl Zeiss Meditec AG Payments of Debt Historical Data

* Premium members only.

The historical data trend for Carl Zeiss Meditec AG's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Carl Zeiss Meditec AG Payments of Debt Chart

Carl Zeiss Meditec AG Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Payments of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only -17.73 -2.05 -0.01 400.00 0.00

Carl Zeiss Meditec AG Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.40 0.00 -0.03 4.22
MIL:1AFX
51GF Score
Carl Zeiss Meditec AG MIL:1AFX
Payments of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Carl Zeiss Meditec AG Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was €4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Payments of Debt →
What does a Payments of Debt of €4 Mil mean?
Carl Zeiss Meditec AG (MIL:1AFX) has a Payments of Debt of €4 Mil as of Mar. 2026. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Carl Zeiss Meditec AG and its competitors.
Is Carl Zeiss Meditec AG's Payments of Debt too high?
Carl Zeiss Meditec AG's current Payments of Debt is €4 Mil. Overall, Carl Zeiss Meditec AG has a GF Score™ of 51/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Carl Zeiss Meditec AG's Payments of Debt compare to ISRG and BDX?
Carl Zeiss Meditec AG's Payments of Debt of €4 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Payments of Debt for a Medical Devices & Instruments company?
A good Payments of Debt depends on the Medical Devices & Instruments industry context. However, Payments of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Payments of Debt mean?
A high Payments of Debt can signal that a stock is expensive relative to its fundamentals. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Carl Zeiss Meditec AG and its competitors. Carl Zeiss Meditec AG's current Payments of Debt is €4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carl Zeiss Meditec AG stock overvalued right now?
Based on GuruFocus' analysis, Carl Zeiss Meditec AG (MIL:1AFX) is currently considered Significantly Undervalued. The stock's GF Value™ is €63.89, compared to a current price of €29.20 — trading 54.3% below its estimated fair value. The current Payments of Debt is €4 Mil. Carl Zeiss Meditec AG's overall GF Score™ is 51/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Payments of Debt calculated?
Payments of Debt is calculated from a company's financial statements. For Carl Zeiss Meditec AG (MIL:1AFX), the current Payments of Debt is €4 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Carl Zeiss Meditec AG (MIL:1AFX) Overvalued in 2026?

Based on GuruFocus' analysis, Carl Zeiss Meditec AG stock appears to be undervalued. The current stock price of €29.20 is trading 54.3% below its estimated GF Value™ of €63.89. GuruFocus considers Carl Zeiss Meditec AG to be Significantly Undervalued.

Key valuation signals for MIL:1AFX:

  • Payments of Debt: €4 Mil
  • GF Value™: €63.89 vs. price of €29.20 (54.3% below fair value)
  • GF Score™: 51/100 with 4 warning signs

No single metric tells the full story. See the MIL:1AFX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Carl Zeiss Meditec AG Business Description

Address Goschwitzer Strasse 51-52, Jena, TH, DEU, 07745
Carl Zeiss Meditec AG is a German medical technology company specializing in ophthalmic devices and microsurgery equipment. It operates through two segments: Ophthalmology, which supplies diagnostic and surgical systems, refractive lasers, intraocular lenses, and disposable instruments used in cataract and vision-correction procedures, and Microsurgery, which provides visualization systems, surgical instruments, and implants for neurosurgery, spine surgery, and otolaryngology. The company serves hospitals, clinics, surgical centers, and eye-care practices worldwide, selling directly and through distributors. Revenue comes mainly from equipment sales, recurring consumables and implants, and service contracts. Europe, the Americas, and Asia-Pacific, particularly China and Japan, are key markets. Carl Zeiss Meditec is majority-owned by Carl Zeiss AG and is listed on the Frankfurt Stock Exchange.
51GF Score

Get the complete analysis for MIL:1AFX

Payments of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€29.20
Price
€63.89
GF Value